High diagnostic potential of short and long read genome sequencing with transcriptome analysis in exome-negative developmental disorders

• Published in: Human genetics 2023-06, Vol.142 (6), p.773-783
• Main Authors: Lecoquierre, François, Quenez, Olivier, Fourneaux, Steeve, Coutant, Sophie, Vezain, Myriam, Rolain, Marion, Drouot, Nathalie, Boland, Anne, Olaso, Robert, Meyer, Vincent, Deleuze, Jean-François, Dabbagh, Dana, Gilles, Isabelle, Gayet, Claire, Saugier-Veber, Pascale, Goldenberg, Alice, Guerrot, Anne-Marie, Nicolas, Gaël
• Format: Article
• Language: English
• Subjects: Biochemistry, Molecular Biology; Bioinformatics; Biomedical and Life Sciences; Biomedicine; Child; Chromosome Mapping; Comparative analysis; Developmental Disabilities - diagnosis; Developmental Disabilities - genetics; DNA sequencing; Ethylenediaminetetraacetic acid; Exome - genetics; Gene deletion; Gene expression; Gene Expression Profiling - methods; Gene Function; Genes; Genetics; Genomes; Genomics; Human Genetics; Humans; Life Sciences; Metabolic Diseases; Molecular Medicine; Neurodevelopmental disorders; Non-coding RNA; Nucleotide sequencing; Original Investigation; Peripheral blood; Pilot Projects; Transcriptomes
• ISSN: 0340-6717; 1432-1203; 1432-1203
• DOI: 10.1007/s00439-023-02553-1

Exome sequencing (ES) has become the method of choice for diagnosing rare diseases, while the availability of short-read genome sequencing (SR-GS) in a medical setting is increasing. In addition, new sequencing technologies, such as long-read genome sequencing (LR-GS) and transcriptome sequencing, are being increasingly used. However, the contribution of these techniques compared to widely used ES is not well established, particularly in regards to the analysis of non-coding regions. In a pilot study of five probands affected by an undiagnosed neurodevelopmental disorder, we performed trio-based short-read GS and long-read GS as well as case-only peripheral blood transcriptome sequencing. We identified three new genetic diagnoses, none of which affected the coding regions. More specifically, LR-GS identified a balanced inversion in NSD1 , highlighting a rare mechanism of Sotos syndrome. SR-GS identified a homozygous deep intronic variant of KLHL7 resulting in a neoexon inclusion, and a de novo mosaic intronic 22-bp deletion in KMT2D , leading to the diagnosis of Perching and Kabuki syndromes, respectively. All three variants had a significant effect on the transcriptome, which showed decreased gene expression, mono-allelic expression and splicing defects, respectively, further validating the effect of these variants. Overall, in undiagnosed patients, the combination of short and long read GS allowed the detection of cryptic variations not or barely detectable by ES, making it a highly sensitive method at the cost of more complex bioinformatics approaches. Transcriptome sequencing is a valuable complement for the functional validation of variations, particularly in the non-coding genome.